BiomeMega Biosciences (Singapore)

BiomeMega Biosciences is a biotechnology company focused on research, development, and supply of probiotic-derived ingredients, specializing in the bio-enhancement and application of Omega 3, 6, 7, and 9 fatty acids. The company utilizes a proprietary platform centered on precision fermentation to isolate and scale bacterial and fungal species capable of producing fatty acids, short-chain fatty acids, and antioxidants. By leveraging genetic constructs and next-generation probiotic-derived ingredients, BiomeMega aims to provide sustainable, non-GMO solutions for the nutraceutical, food, and pharmaceutical industries, including the development of functional peptides and post-biotic membranes.

These innovations are designed to address chronic health issues by potentially serving as therapeutic agents or as models for improving chemical synthesis. Through collaborations with universities and industry partners, BiomeMega aims to transform human health by improving cell function and preventing diseases associated with modern lifestyles. The company’s research pipeline, supported by preclinical trials demonstrating benefits such as lean muscle growth and metabolic health, positions its probiotic membrane technology for applications in health products, cosmetics, and cardiovascular medicine.